137 related articles for article (PubMed ID: 34634467)
1. Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery.
Braet H; Rahimi-Gorji M; Debbaut C; Ghorbaniasl G; Van Walleghem T; Cornelis S; Cosyns S; Vervaet C; Willaert W; Ceelen W; De Smedt SC; Remaut K
Eur J Pharm Biopharm; 2021 Dec; 169():134-143. PubMed ID: 34634467
[TBL] [Abstract][Full Text] [Related]
2. CO
Braet H; Fransen PP; Mariën R; Lollo G; Ceelen W; Vervaet C; Balcaen L; Vanhaecke F; Vanhove C; van der Vegte S; Gasthuys E; Vermeulen A; Dankers PYW; De Smedt SC; Remaut K
ACS Appl Mater Interfaces; 2023 Oct; 15(42):49022-49034. PubMed ID: 37819736
[TBL] [Abstract][Full Text] [Related]
3. A supramolecular host-guest interaction-mediated injectable hydrogel system with enhanced stability and sustained protein release.
Lee SY; Jeon SI; Sim SB; Byun Y; Ahn CH
Acta Biomater; 2021 Sep; 131():286-301. PubMed ID: 34246803
[TBL] [Abstract][Full Text] [Related]
4. The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines.
Braet H; Andretto V; Mariën R; Yücesan B; van der Vegte S; Haegebaert R; Lollo G; De Smedt SC; Remaut K
Acta Biomater; 2023 Oct; 170():318-329. PubMed ID: 37598790
[TBL] [Abstract][Full Text] [Related]
5. High Pressure Nebulization (PIPAC) Versus Injection for the Intraperitoneal Administration of mRNA Complexes.
Shariati M; Zhang H; Van de Sande L; Descamps B; Vanhove C; Willaert W; Ceelen W; De Smedt SC; Remaut K
Pharm Res; 2019 Jun; 36(9):126. PubMed ID: 31236829
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal aerosolized drug delivery: Technology, recent developments, and future outlook.
Rahimi-Gorji M; Van de Sande L; Debbaut C; Ghorbaniasl G; Braet H; Cosyns S; Remaut K; Willaert W; Ceelen W
Adv Drug Deliv Rev; 2020; 160():105-114. PubMed ID: 33132169
[TBL] [Abstract][Full Text] [Related]
7. Mucin-mediated mucosal retention via end-terminal modified Pluronic F127-based hydrogel to increase drug accumulation in the lungs.
Wu TY; Huang CC; Tsai HC; Lin TK; Chen PY; Darge HF; Hong ZX; Harn HJ; Lin SZ; Lai JY; Chen YS
Biomater Adv; 2024 Jan; 156():213722. PubMed ID: 38101076
[TBL] [Abstract][Full Text] [Related]
8. Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology.
Li Z; Perkins W; Cipolla D
Eur J Pharm Biopharm; 2021 Sep; 166():10-18. PubMed ID: 34082122
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of thermosensitive Pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites.
Wen Q; Zhang Y; Luo J; Xiong K; Lu Y; Wu Z; Wang BQ; Wu J; Chen Y; Fu S
Int J Pharm; 2020 May; 582():119334. PubMed ID: 32305362
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
[TBL] [Abstract][Full Text] [Related]
11. Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids.
Aka-Any-Grah A; Bouchemal K; Koffi A; Agnely F; Zhang M; Djabourov M; Ponchel G
Eur J Pharm Biopharm; 2010 Oct; 76(2):296-303. PubMed ID: 20656027
[TBL] [Abstract][Full Text] [Related]
12. Pluronic/gelatin composites for controlled release of actives.
Tatini D; Tempesti P; Ridi F; Fratini E; Bonini M; Baglioni P
Colloids Surf B Biointerfaces; 2015 Nov; 135():400-407. PubMed ID: 26277715
[TBL] [Abstract][Full Text] [Related]
13. In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer.
Gong CY; Shi S; Dong PW; Zheng XL; Fu SZ; Guo G; Yang JL; Wei YQ; Qian ZY
BMC Biotechnol; 2009 Feb; 9():8. PubMed ID: 19210779
[TBL] [Abstract][Full Text] [Related]
14. Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling.
Rahimi-Gorji M; Debbaut C; Ghorbaniasl G; Cosyns S; Willaert W; Ceelen W
Sci Rep; 2022 Apr; 12(1):6305. PubMed ID: 35428819
[TBL] [Abstract][Full Text] [Related]
15. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
Al Khateb K; Ozhmukhametova EK; Mussin MN; Seilkhanov SK; Rakhypbekov TK; Lau WM; Khutoryanskiy VV
Int J Pharm; 2016 Apr; 502(1-2):70-9. PubMed ID: 26899977
[TBL] [Abstract][Full Text] [Related]
16. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
17. Study in vivo intraocular biocompatibility of in situ gelation hydrogels: poly(2-ethyl oxazoline)-block-poly(ε-caprolactone)-block-poly(2-ethyl oxazoline) copolymer, matrigel and pluronic F127.
Hwang YS; Chiang PR; Hong WH; Chiao CC; Chu IM; Hsiue GH; Shen CR
PLoS One; 2013; 8(7):e67495. PubMed ID: 23840873
[TBL] [Abstract][Full Text] [Related]
18. Injectable Nanosponge-Loaded Pluronic F127 Hydrogel for Pore-Forming Toxin Neutralization.
Zou S; He Q; Wang Q; Wang B; Liu G; Zhang F; Cheng X; Wang B; Zhang L
Int J Nanomedicine; 2021; 16():4239-4250. PubMed ID: 34194227
[TBL] [Abstract][Full Text] [Related]
19. Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development.
Shriky B; Kelly A; Isreb M; Babenko M; Mahmoudi N; Rogers S; Shebanova O; Snow T; Gough T
J Colloid Interface Sci; 2020 Apr; 565():119-130. PubMed ID: 31945671
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic Intraperitoneal Aerosol Delivery of Nanoparticles: Proof of Concept and Preclinical Validation.
Van de Sande L; Rahimi-Gorji M; Giordano S; Davoli E; Matteo C; Detlefsen S; D'Herde K; Braet H; Shariati M; Remaut K; Xie F; Debbaut C; Ghorbaniasl G; Cosyns S; Willaert W; Ceelen W
Adv Healthc Mater; 2020 Aug; 9(16):e2000655. PubMed ID: 32548967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
